Preparing our Paralympians: research and development at Ossur, UK. Interview by Sarah A. Curran.

Autor: Hirons R; Wales Centre for Podiatric Studies, Cardiff Metropolitan University, Cardiff, UK.

Publikováno v: Prosthetics and orthotics international [Prosthet Orthot Int] 2012 Sep; Vol. 36 (3), pp. 366-9.

Research and development at novel GmbH, Germany for prosthetics and paraplegics. Interview by Sarah A. Curran.

Autor: Kalpen A; Wales Centre for Podiatric Studies, Cardiff Metropolitan University, Cardiff, UK.

Publikováno v: Prosthetics and orthotics international [Prosthet Orthot Int] 2012 Sep; Vol. 36 (3), pp. 376-9.

A genetics-first approach to dissecting the heterogeneity of autism: phenotypic comparison of autism risk copy number variants

Autor: Carrie E. Bearden, Marianne Bernadette van den Bree, Samuel J.R.A. Chawner, Leila Kushan, Louise Gallagher, Jeremy Hall, Wendy R. Kates, Kevin M. Antshel, Joanne L. Doherty, Judith S Miller, Caitlin C. Clements, Hayley Moss, Goran Cuturilo, A. Maillard, Raquel E. Gur, Sarah R Curran, LeeAnne Green-Snyder, Tara L. Wenger, Wendy K Chung, Michael J Owen, Richard Anney, Jacob Vorstman, Robert T. Schultz, Milica Pejovic-Milovancevic, Robin P. Goin-Kochel, Sébastien Jacquemont, Ellen Hanson, D M McDonald-McGinn, Raphael Bernier, Marina Mihaljevic, Ania M Fiksinski

Objective: Certain copy number variants (CNVs) greatly increase the risk of autism. The authors conducted a genetics-first study to investigate whether heterogeneity in the clinical presentation of autism is underpinned by specific genotype-phenotype

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b2a71567fba7bdaac36b3b97eefed4c8

Contributors

Autor: Cheryl Achary, Asra Ahmad, Leanne Atkin, Daniel R. Bonanno, Frank Bowling, Christopher Broomhead, J Gordon Burrow, Matthew Carroll, Matthew Cotchett, Hugh Cross, Mike Cummings, Martina Nicola Cummins, Sarah A. Curran, Michael Edmonds, Angela Margaret Evans, Peter Fisher, Malindu Fernando, Martin Fox, Barry E. Francis, Paul Jarrett, Haydn D. Kelly, Mohammed Tariq Khan, Timothy Kilmartin, Karl Landorf, Peter Lazzarini, Heinz Lohrer, Donald L. Lorimer, Felix Lopez, Claire MacGilchrist, Peter Madigan, Susan Matthews, Mairin McGuinness, Prue Molyneux, Maureen O’Donnell, Nat Padhiar, Ciaran Padhiar, Peter Isaac Thomas Paisley, Sharon Rees, Keith Rome, Mike Graham Serpell, Christine M. Skinner, Pamela Smith, Stephanie J. Smith, Sarah Stewart, Mark Tagoe, Kathryn Taylor, Dawn Thompson, Deborah Turner, Francisco Vega-López, James Watkins, Anita Williams, Anne Whinfield

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::2411aae0201cf77f484cb72abfa9b023
https://doi.org/10.1016/b978-0-7020-6223-0.01002-5

Treatment-resistant schizophrenia: current insights on the pharmacogenomics of antipsychotics

Autor: John Lally, Sarah R Curran, Fiona Gaughran, Philip Timms

Publikováno v: Lally, J, Gaughran, F, Timms, P & Curran, S R 2016, ' Treatment-resistant schizophrenia : Current insights on the pharmacogenomics of antipsychotics ', Pharmacogenomics and Personalized Medicine, vol. 9, pp. 117-129 . https://doi.org/10.2147/PGPM.S115741
Pharmacogenomics and Personalized Medicine

Up to 30% of people with schizophrenia do not respond to two (or more) trials of dopaminergic antipsychotics. They are said to have treatment-resistant schizophrenia (TRS). Clozapine is still the only effective treatment for TRS, although it is under

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ec5d6283648f8a7db3c1bc8d61767ec8
https://doi.org/10.2147/pgpm.s115741